CHRS
Closed
Coherus Biosciences Inc
0.7603
+0.0290 (+3.97%)
Last Update: 01 Jul 2025 23:19:00
Yesterday: 0.7313
Day's Range: 0.72 - 0.7603
Send
sign up or login to leave a comment!
When Written:
6.84
Coherus BioSciences Inc. is a biotechnology company that develops and commercializes biosimilar drugs. Biosimilars are highly similar versions of existing biologic drugs that have been approved by regulatory agencies such as the FDA. Coherus focuses on developing biosimilars for the treatment of autoimmune diseases, cancer, and other chronic conditions. The company's lead product is UDENYCA, a biosimilar to Neulasta, which is used to reduce the risk of infection in patients receiving chemotherapy. Coherus is headquartered in Redwood City, California and was founded in 2010.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








